Evolent Health, Inc. (EVH)
NYSE: EVH · Real-Time Price · USD
3.840
+0.230 (6.37%)
Oct 6, 2026, 4:00 PM EDT - Market closed
Evolent Health Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 434 | 446 | 1,294 | 3,797 | 2,798 | 2,431 | |
Market Cap Growth | -55.11% | -65.50% | -65.92% | 35.70% | 15.09% | 79.91% |
Enterprise Value | 1,289 | 1,412 | 2,020 | 4,442 | 3,119 | 2,481 |
Last Close Price | 3.84 | 4.00 | 11.25 | 33.03 | 28.08 | 27.67 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | 10.93 | 16.88 | 13.66 | 38.40 | 44.32 | 57.19 |
PS Ratio | 0.21 | 0.24 | 0.51 | 1.93 | 2.07 | 2.68 |
PB Ratio | 1.13 | 1.08 | 1.09 | 3.05 | 3.26 | 3.51 |
P/FCF Ratio | 5.40 | 93.88 | - | 33.36 | - | 216.09 |
P/OCF Ratio | 7.99 | 11.49 | 68.96 | 26.63 | - | 62.75 |
PEG Ratio | - | 1.91 | 1.91 | 1.91 | 1.91 | 1.91 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.61 | 0.75 | 0.79 | 2.26 | 2.31 | 2.73 |
EV/EBITDA Ratio | 21.12 | 16.01 | 21.24 | 40.05 | 153.52 | 153.84 |
EV/EBIT Ratio | - | - | 84.36 | 313.22 | - | - |
EV/FCF Ratio | 16.03 | 296.96 | - | 39.02 | - | 220.47 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 2.53 | 2.38 | 0.60 | 0.52 | 0.55 | 0.40 |
Debt / EBITDA Ratio | 14.99 | 10.69 | 6.90 | 5.16 | 13.62 | 8.21 |
Debt / FCF Ratio | 12.07 | 208.14 | - | 5.66 | - | 24.93 |
Net Debt / Equity Ratio | 2.23 | 2.02 | 0.51 | 0.36 | 0.34 | 0.02 |
Net Debt / EBITDA Ratio | 14.00 | 9.50 | 6.41 | 4.08 | 14.17 | 0.88 |
Net Debt / FCF Ratio | 10.63 | 176.20 | -42.46 | 3.97 | -4.87 | 1.26 |
Asset Turnover | 0.95 | 0.84 | 0.98 | 0.87 | 0.84 | 0.65 |
Quick Ratio | 1.15 | 1.20 | 0.73 | 0.95 | 1.02 | 0.89 |
Current Ratio | 1.24 | 1.31 | 0.85 | 1.01 | 1.10 | 1.18 |
Return on Equity (ROE) | -66.97% | -66.54% | -5.06% | -10.74% | -2.41% | -4.61% |
Return on Assets (ROA) | -0.78% | -0.13% | 0.57% | 0.39% | -0.77% | -0.78% |
Return on Invested Capital (ROIC) | -2.25% | -0.29% | 1.37% | 1.00% | -2.14% | -2.54% |
Return on Capital Employed (ROCE) | -1.90% | -0.30% | 1.30% | 0.70% | -1.40% | -1.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -117.71% | -119.74% | -4.76% | -2.98% | -0.69% | -1.55% |
FCF Yield | 18.52% | 1.06% | -1.11% | 3.00% | -2.11% | 0.46% |
Buyback Yield / Dilution | 2.39% | 0.41% | -3.08% | -18.73% | -8.87% | -1.34% |